UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:
April 4, 2022
Accession Number:
Submission Type:
CIK:
0000910267
Company Name:
TITAN PHARMACEUTICALS INC
File Number:
333-262614